🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To ascertain whether there are fewer adhesions (internal scars) formed foll...
Status
Completed
Location
The Royal Surrey County Hospital
Start Date
2006-06
Trial ID
NCT00530322
Treatments Being Tested
In the past, the investigators often treated giant cavernous hemangiomas of...
Status
Completed
Location
Institute of hepatobiliary surgery,southwest hospital
Start Date
2011-11
Trial ID
NCT01471080
Treatments Being Tested
To prospectively collect and evaluate pre-operative, intra-operative, and p...
Status
Completed
Location
Atrium Health
Start Date
2022-02-14
Trial ID
NCT05471596
Treatments Being Tested
Living donor liver transplantation (LDLT) is an important option for patien...
Status
Completed
Location
Samsung Medical Center
Start Date
2015-03
Trial ID
NCT02413983
Treatments Being Tested
This study is a randomized controlled trial designed to investigate the eff...
Status
Completed
Location
Sun Yat-san University Cancer Center
Start Date
2024-06-20
Trial ID
NCT06714669
Treatments Being Tested
aimed to discuss the short term surgical outcomes of Anatomical versus Non ...
Status
Unknown
Location
Sohag University
Start Date
2021-12-01
Trial ID
NCT06271109
This study aimed to evaluate the safety, feasibility and efficacy of laparo...
Status
Unknown
Location
Southwest Hospital
Start Date
2019-09-25
Trial ID
NCT04499261
Treatments Being Tested
Hepatocellular carcinoma (HCC) accounts for more than 90% of primary liver ...
Status
Completed
Location
Sun Yat-Sen University Cancer Center
Start Date
2022-05-05
Trial ID
NCT05349331
Treatments Being Tested
Rationale: Adhesion formation is a frequent complication after abdominal su...
Status
Completed
Location
Radboud University Nijmegen Medical Center
Start Date
2013-01
Trial ID
NCT01720966
Treatments Being Tested
As the most common subtype of liver cancer (85% \~ 90%), HCC is highly mali...
Status
Completed
Location
Multiple Locations
Start Date
2008-01-01
Trial ID
NCT05796700
Treatments Being Tested